본문으로 건너뛰기
← 뒤로

Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation.

1/5 보강
Transplantation and cellular therapy 📖 저널 OA 24.2% 2025: 2/13 OA 2026: 20/78 OA 2025~2026 2026 Vol.32(4) p. 454-465
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
2 patients with lung cancer as controls.
I · Intervention 중재 / 시술
lung transplantation, with tissues from 2 patients with lung cancer as controls
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
These findings indicate that MMT contributes to fibrosis in BO. Gene expression shifts from inflammation to fibrosis as the disease advances, underscoring the importance of early intervention.

Yamamoto A, Fujii N, Seike K, Sugimoto S, Naoi Y, Nagano T, Kubota S, Kambara Y, Fujiwara K, Terao T, Oyama T, Kunihiro M, Kobayashi H, Kondo T, Fujiwara H, Asada N, Ennishi D, Fujii K, Toyooka S, Maeda Y

📝 환자 설명용 한 줄

Bronchiolitis obliterans (BO) is a severe, fibrotic manifestation of chronic graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT).

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yamamoto A, Fujii N, et al. (2026). Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation.. Transplantation and cellular therapy, 32(4), 454-465. https://doi.org/10.1016/j.jtct.2025.12.950
MLA Yamamoto A, et al.. "Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation.." Transplantation and cellular therapy, vol. 32, no. 4, 2026, pp. 454-465.
PMID 41429336 ↗

Abstract

Bronchiolitis obliterans (BO) is a severe, fibrotic manifestation of chronic graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). Macrophage-derived TGF-β is linked to GVHD-related fibrosis; however, its role in BO remains unclear. Given emerging evidence of macrophage-to-myofibroblast transition (MMT) in fibrosis, this study aimed to investigate whether MMT contributes to BO development. We analyzed lung samples from 3 HSCT recipients with BO who underwent lung transplantation, with tissues from 2 patients with lung cancer as controls. Immunofluorescent staining for CD68, CD206, and α-SMA was used to identify cells undergoing MMT. Spatial transcriptomics was performed to profile gene expression in foamy macrophages across anatomical regions and histological stages, compared to control peribronchiolar regions. Immunostaining showed strong co-expression of CD68, CD206, and α-SMA in foamy macrophages within and surrounding bronchioles in BO samples, with minimal expression in controls, suggesting MMT involvement. In BO, spatial transcriptomics revealed upregulation of macrophage- and TGF-β signaling genes, with distinct stage- and region-specific gene expression patterns. Unsupervised clustering revealed a shift from inflammation to fibrosis. These findings indicate that MMT contributes to fibrosis in BO. Gene expression shifts from inflammation to fibrosis as the disease advances, underscoring the importance of early intervention.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반